pargyline has been researched along with n-methylaspartate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chergui, K; Chouvet, G; Gonon, F; Suaud-Chagny, MF | 1 |
| Engel, JA; Hulthe, P; Johannessen, K; Svensson, L; Wu, C | 1 |
| Boldry, RC; Uretsky, NJ | 1 |
| Hsu, KS; Huang, CC; Su, MT; Tsai, JJ | 1 |
| Leonardi, EK; Mytilineou, C; Olanow, CW; Radcliffe, P; Werner, P | 1 |
| Chappell, RL; Schuette, E | 1 |
| Haapalinna, A; Niittykoski, M; Sirviö, J | 1 |
7 other study(ies) available for pargyline and n-methylaspartate
| Article | Year |
|---|---|
Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area.
Topics: Animals; Brain; Dopamine; Electrophysiology; Evoked Potentials; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Male; N-Methylaspartate; Neurons; Nucleus Accumbens; Pargyline; Quisqualic Acid; Rats; Rats, Wistar; Stereotaxic Techniques | 1992 |
Rapid changes in ascorbate and dopamine release in rat nucleus accumbens after intracerebroventricular administration of NMDA.
Topics: Animals; Anticonvulsants; Ascorbic Acid; Atropine; Cerebral Ventricles; Dopamine; Injections, Intraventricular; Male; Membrane Potentials; N-Methylaspartate; Neurons; Nucleus Accumbens; Pargyline; Picrotoxin; Piperazines; Rats; Rats, Inbred Strains; Time Factors | 1992 |
The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Aspartic Acid; Dopamine; Dopamine Antagonists; Drug Combinations; Haloperidol; In Vitro Techniques; Locomotion; Male; Methyltyrosines; N-Methylaspartate; Nucleus Accumbens; Pargyline; Potassium; Rats; Rats, Inbred Strains; Reserpine; Septal Nuclei; Synaptic Transmission; Tyrosine 3-Monooxygenase | 1988 |
L-deprenyl (selegiline) decreases excitatory synaptic transmission in the rat hippocampus via a dopaminergic mechanism.
Topics: Animals; Anticonvulsants; Dopamine; Dose-Response Relationship, Drug; Glutamine; Hippocampus; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; N-Methylaspartate; Pargyline; Picrotoxin; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Selegiline; Synaptic Transmission | 1996 |
L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cell Death; Culture Media; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Mesencephalon; Monoamine Oxidase Inhibitors; N-Methylaspartate; Neurons; Neuroprotective Agents; Pargyline; Rats; Receptors, Glutamate; Selegiline | 1997 |
Excitatory amino acids and serotonin uptake blockers reveal two physiologically distinct serotonin systems in the retina of the skate, Raja erinacea.
Topics: Animals; Aspartic Acid; Excitatory Amino Acid Antagonists; Fluoxetine; Monoamine Oxidase Inhibitors; N-Methylaspartate; Organ Culture Techniques; Pargyline; Potassium; Retina; Selective Serotonin Reuptake Inhibitors; Serotonin; Skates, Fish; Zimeldine | 1998 |
Selegiline reduces N-methyl-D-aspartic acid induced perturbation of neurotransmission but it leaves NMDA receptor dependent long-term potentiation intact in the hippocampus.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Monoamine Oxidase Inhibitors; N-Methylaspartate; Neurons; Pargyline; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Selegiline; Synaptic Transmission | 2003 |